Kamau to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its homology-directed repair (HDR) novel gene correction technology ROCKVILLE, Md. and SOUTH SAN FRANCISCO, Calif. — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and […]
Partnership announced between Canopy Biosciences – A Bruker Company – and Navinci Diagnostics AB We are pleased to announce that Navinci’s innovative in situ proximity ligation technology can now be offered by Canopy Biosciences as part of their CRO service lab, enabling more researchers than ever to visualise and quantify proteins, protein-protein interactions and post-translational modifications in situ. […]
Parting and future CEO of abberior instruments: Dr. Gerald Donnert (top) und Dr. Thorsten Staudt Göttingen, Germany — abberior instruments GmbH CEO Dr. Gerald Donnert will hand over his position to Dr. Thorsten Staudt on January 1, 2025. “I am delighted to be returning to microscopy, to further develop abberior instruments as a team and to […]
GT Molecular, Inc., a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer research, and pathogen detection, was awarded the Center for Disease Control’s (CDC) National Wastewater Surveillance System (NWSS), Multi-Pathogen Assay Development Optimization, Validation, and Support contract. This work will build upon previously successful contracts with the CDC and incorporate emerging public health threat […]
Shimadzu Corporation has invested in Symbiobe Inc. (Symbiobe), through its Corporate Venture Capital (CVC) fund, “Shimadzu Future Innovation Fund” (Shimadzu FIF). Symbiobe is a startup originating from Kyoto University that develops carbon dioxide and nitrogen fixation technology using photosynthetic organisms*. Founded in 2021, Symbiobe aims to solve social issues such as climate change and resource […]
Wilsonville, OR facility LEED v4.1 Operations + Maintenance certified SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the U.S. Green Building Council (USGBC) awarded the company’s Wilsonville, OR facility LEED certification, meeting sustainability standards for its building, operations and […]
EcoVadis Rating validates Avantor’s business sustainability commitments and performance RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced today, for the second year in a row, that the Company has been awarded a Bronze Medal from EcoVadis, a global […]
The global collective intelligence network aims to accelerate precision oncology research and care. Boston, US, and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update that several world-renowned healthcare organizations have joined SOPHiA UNITY. SOPHiA UNITY is the global consortium announced at ASCO by SOPHiA […]
PISCATAWAY, N.J. — GenScript Biotech Corporation (“GenScript”), a global leader in life sciences products and services, announced the appointment of Dr. Ross Allen Grossman as a Non-Executive Director and Dr. Alphonse Galdes as an Independent Non-Executive Director. These appointments not only further diversify the Group’s Board but also highlight GenScript’s commitment to building an international, diverse, and highly specialized corporate […]
Cellares and Sony will collaborate on integrating Sony’s cell sorting and analytical technologies into the Cell Shuttle, Cellares’ automated cell therapy manufacturing platform Integration of this technology will enable the Cell Shuttle to efficiently automate the manufacture of sorting-dependent modalities such as regulatory T cell therapies (Tregs) and hematopoietic stem cell therapies (HSCs) Additionally, this […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
